カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

在宅医療のグローバル市場予測（～2028）：透析装置、人工呼吸器、HIV検査キット、補聴器、活動モニタ

■ 英語タイトル：Home Healthcare Market by Product (Dialysis Equipment, Ventilators, HIV Test Kits, Hearing Aids, Activity Monitors), Service (Skilled Nursing, Infusion Therapy, Palliative Care), Indication (Cancer, Wound Care, Diabetes), & Region- Global Forecast to 2028

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：MD1160-24）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：MD1160-24
■ 発行日：2024年2月6日
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：342
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[在宅医療のグローバル市場予測（～2028）：透析装置、人工呼吸器、HIV検査キット、補聴器、活動モニタ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

"世界の在宅医療市場は、2023年の2,500億米ドルから2028年には3,830億米ドルに達すると予測され、予測期間中の年平均成長率は8.9%" この市場の成長の主な原動力は、在宅医療用品とサービスにおける新技術の導入です。

"予測期間中、在宅医療市場において製品別で最も高い成長率を占めたのは治療用製品分野"
検査・スクリーニング・モニタリング用製品、治療用製品、移動ケア用アイテムが在宅医療市場のセグメントを構成しています。2022年の在宅医療市場で最も高い成長率を記録したのは治療用品のカテゴリーです。慢性疾患の増加が市場拡大の主因です。

"輸液療法サービス分野が最も高いCAGRを占める"
熟練看護、リハビリテーション治療、ホスピス＆緩和ケア、未熟練ケア、呼吸療法、輸液療法、妊産婦ケアサービスは、在宅医療市場を構成するいくつかのサービスカテゴリーです。2022年までに最も成長率が高いカテゴリーは熟練看護サービス。これは都市化と人口増加によるものです。

"アジア太平洋地域：在宅医療市場が最も急成長する地域"
世界の在宅医療市場は、北米、欧州、アジア太平洋地域、その他の地域に区分されます。予測期間中、アジア太平洋地域が最大のCAGRを記録する見込みです。医療費の増加や在宅ケアを支援する政府の試みなどの要因があります。

供給側の一次面接の内訳です。
- 企業タイプ別：ティア1（40％）、ティア2（30％）、ティア3（30%）
- 役職別：Cレベル（27％）、ディレクターレベル（18％）、その他（55%）
- 地域別：北米(51%)、欧州(21%)、アジア太平洋(18%)、中南米(6%)、中東・アフリカ(4%)

この市場に参入している主要企業には、Fresenius SE & Co. KGaA (Germany), Abbott (US), GE HealthCare (US), Koninklijke Phillips NV. (Netherlands), ResMed, Inc. (US), Linde plc (Ireland), F. Hoffman-La Roche, Ltd. (Switzerland), A&D Company Limited (Japan), Bayade Home Health Care (US), Invacare Corporation (US), Amedisys (US), LHC Group, Inc. (US), OMRON Corporation (Japan), Drive DeVilbiss Healthcare (UK), Sunrise Medical (Germany), Roma Medical (UK), CAREMAX Rehabilitation Equipment Co., Ltd. (China), Vitalograph (UK), Advita Rflegedienst GmbH (Germany), RENAFAN GmbH (Germany), CONTEC MEDICAL SYSTEMS Co., Ltd. (China), B. Braun Melsungen Ag (Germany), Baxter International, Inc. (US), Medline Industries, Inc. (US), and Advin Health Care (India)などがあります。

調査範囲
この調査レポートは、在宅医療市場を製品、サービス、指標、地域別に分類しています。在宅医療市場の成長に影響を与える促進要因、阻害要因、課題、機会などの主要要因に関する詳細情報を網羅しています。主要な業界プレイヤーを詳細に分析し、事業概要、ソリューション、サービス、主要戦略、契約、パートナーシップ、合意、新製品・サービスの発表、M&A、表面消毒剤市場に関連する最近の動向などに関する洞察を提供します。在宅医療市場のエコシステムにおける今後の新興企業の競合分析もカバーしています。

本レポートを購入する理由
本レポートは、在宅医療市場全体およびサブセグメントの収益数の最も近い近似値に関する情報を提供することで、同市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競合状況を理解し、より深い洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します。
- 在宅医療市場の成長に影響を与える主な促進要因（慢性疾患の高蔓延、老人人口の増加）、抑制要因（代替技術）、機会（医療費の増加、新興経済圏からの需要増加）、課題（厳しい規制、保険適用範囲の制限）の分析を提供します。
- 製品開発/イノベーション：在宅医療市場における今後の技術、研究開発活動、新製品・サービス開始に関する詳細な洞察を提供します。
- 市場開発：有利な市場に関する包括的な情報 - 本レポートは様々な地域の在宅医療市場を分析しています。
- 市場の多様化：在宅医療市場における新製品、未開拓地域、最近の開発、投資に関する詳細情報を提供します。
- 競合評価：Fresenius SE & Co. KGaA (Germany), Abbott (US), GE HealthCare (US), Koninklijke Phillips NV. (Netherlands), ResMed, Inc. (US)などの企業を分析しています。

1 イントロダクション
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 在宅医療の世界市場規模：製品別
7 在宅医療の世界市場規模：サービス別
8 在宅医療の世界市場規模：疾患別
9 在宅医療の世界市場規模：地域別
10 競争状況
11 企業情報
12 付録

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 INTRODUCTION (Page No. – 37)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. – 42)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 1 HOME HEALTHCARE MARKET: RESEARCH DESIGN METHODOLOGY
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
TABLE 2 KEY DATA FROM PRIMARY SOURCES
2.2.2.1 Key industry insights
2.2.2.2 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HOME HEALTHCARE INDUSTRY)
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 Approach 2: Presentations of companies and primary interviews
2.3.1.3 Growth forecast
2.3.1.4 CAGR projections
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 6 HOME HEALTHCARE INDUSTRY: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ANALYSIS
2.6 ASSUMPTIONS
2.7 GROWTH RATE ASSUMPTIONS
2.8 LIMITATIONS
2.9 RISK ASSESSMENT
2.10 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY (Page No. – 55)
FIGURE 8 HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD BILLION)
FIGURE 9 HOME HEALTHCARE INDUSTRY, BY PRODUCT, 2023 VS. 2028 (USD BILLION)
FIGURE 10 MARKET, BY SERVICE, 2023 VS. 2028 (USD BILLION)
FIGURE 11 MARKET, BY INDICATION, 2023 VS. 2028 (USD BILLION)
FIGURE 12 MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS (Page No. – 59)
4.1 HOME HEALTHCARE MARKET OVERVIEW
FIGURE 13 RISING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH
4.2 GEOGRAPHIC GROWTH OPPORTUNITIES IN HOME HEALTHCARE INDUSTRY
FIGURE 14 JAPAN AND CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.3 MARKET: GEOGRAPHIC MIX
FIGURE 15 APAC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
4.4 HOME HEALTHCARE INDUSTRY: DEVELOPED MARKETS VS. EMERGING ECONOMIES
FIGURE 16 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. – 63)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rapid growth in elderly population and rising incidence of chronic diseases
TABLE 3 GERIATRIC POPULATION, 2022 VS. 2050 (MILLION)
5.2.1.2 Rising R&D investments
TABLE 4 PRODUCT LAUNCHES
5.2.1.3 Need for cost-effective healthcare delivery due to rising costs
5.2.1.4 Increased preference for personalized care
5.2.2 RESTRAINTS
5.2.2.1 Changing reimbursement policies
5.2.2.2 Limited insurance coverage
5.2.2.3 Patient safety concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Rising focus on telehealth
5.2.3.2 Untapped developing regions
5.2.3.3 Growing demand for home-use therapeutic devices
5.2.3.4 Growing demand for home sleep apnea tests
5.2.3.5 Rising preference for home hemodialysis treatment
5.2.4 CHALLENGES
5.2.4.1 Shortage of home care workers
5.2.4.2 Lack of supporting infrastructure
5.3 PRICING ANALYSIS
5.3.1 PRICING MODEL ANALYSIS
TABLE 5 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS (2023)
TABLE 6 AVERAGE SELLING PRICE OF HOME HEALTHCARE PRODUCTS, BY REGION (2023)
5.4 PATENT ANALYSIS
FIGURE 18 PATENT ANALYSIS FOR TEMPERATURE MONITORING DEVICES (JANUARY 2013–DECEMBER 2022)
5.4.1 LIST OF KEY PATENTS
5.5 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 20 HOME HEALTHCARE INDUSTRY: SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM/MARKET MAP
FIGURE 21 MARKET: ECOSYSTEM/MARKET MAP
5.7.1 MARKET: ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 PULSE OXIMETERS
TABLE 7 PULSE OXIMETERS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1.1 Threat of new entrants
5.8.1.2 Threat of substitutes
5.8.1.3 Bargaining power of suppliers
5.8.1.4 Bargaining power of buyers
5.8.1.5 Degree of competition
5.8.2 HEARING AIDS
TABLE 8 HEARING AIDS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.2.1 Threat of new entrants
5.8.2.2 Threat of substitutes
5.8.2.3 Bargaining power of buyers
5.8.2.4 Bargaining power of suppliers
5.8.2.5 Degree of competition
5.9 PESTLE ANALYSIS
5.10 REGULATORY LANDSCAPE
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.1 NORTH AMERICA
5.10.1.1 US
TABLE 14 US FDA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 22 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
5.10.1.2 Canada
TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 23 APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA
5.10.2 EUROPE
FIGURE 24 CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES
5.10.3 ASIA PACIFIC
5.10.3.1 Japan
TABLE 17 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES
5.10.3.2 China
TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.10.3.3 India
5.11 TRADE ANALYSIS
5.11.1 TRADE ANALYSIS FOR BLOOD PRESSURE MONITORS
TABLE 19 IMPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 20 EXPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017–2021 (USD MILLION)
5.12 TECHNOLOGY ANALYSIS
5.13 KEY CONFERENCES & EVENTS IN 2023–2024
TABLE 21 HOME HEALTHCARE INDUSTRY: KEY CONFERENCES & EVENTS, 2023–2024
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 25 REVENUE SHIFT IN HOME HEALTHCARE
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS
5.15.2 BUYING CRITERIA
FIGURE 27 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS
TABLE 23 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS
5.16 CASE STUDY ANALYSIS
5.16.1 CASE STUDY: FUTURE OF HOME HEALTH PROJECT

6 HOME HEALTHCARE MARKET, BY PRODUCT (Page No. – 102)
6.1 INTRODUCTION
TABLE 24 HOME HEALTHCARE INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 THERAPEUTIC PRODUCTS
TABLE 25 KEY THERAPEUTIC PRODUCTS OFFERED
TABLE 26 THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 27 THERAPEUTIC PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1 DIALYSIS EQUIPMENT
6.2.1.1 Dialysis equipment to hold largest market share
TABLE 28 DIALYSIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2 WOUND CARE PRODUCTS
6.2.2.1 Decreased costs and higher convenience and comfort to drive market
TABLE 29 WOUND CARE PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.3 IV EQUIPMENT
6.2.3.1 Accuracy and growing target disease prevalence to ensure market growth
TABLE 30 IV EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.4 SLEEP APNEA THERAPEUTIC DEVICES
6.2.4.1 Increasing patient preference for home-based sleep tests to fuel market
TABLE 31 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.5 INSULIN DELIVERY DEVICES
6.2.5.1 High incidence of diabetes to drive market
TABLE 32 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.6 OXYGEN DELIVERY SYSTEMS
6.2.6.1 Technological advancements in oxygen therapy products to drive market
TABLE 33 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.7 INHALERS
6.2.7.1 High incidence of asthma to boost market
TABLE 34 INHALERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.8 NEBULIZERS
6.2.8.1 Effectiveness over oral dosages to push preference for nebulizers
TABLE 35 NEBULIZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.9 VENTILATORS
6.2.9.1 Convenience and comfort to sustain end-user preference
TABLE 36 VENTILATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.10 OTHER THERAPEUTIC PRODUCTS
TABLE 37 OTHER THERAPEUTIC PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
6.3 TESTING, SCREENING, AND MONITORING PRODUCTS
TABLE 38 KEY TESTING, SCREENING, AND MONITORING PRODUCTS OFFERED
TABLE 39 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 40 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1 BLOOD GLUCOSE MONITORS
6.3.1.1 Increasing prevalence of diabetes to drive market growth
TABLE 41 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 HEARING AIDS
6.3.2.1 High incidence of hearing impairment to drive market
TABLE 42 HEARING AIDS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.3 ACTIVITY MONITORS & WRISTBANDS
6.3.3.1 Increasing prevalence of chronic diseases to bolster demand for activity monitors
TABLE 43 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.4 ECG/EKG DEVICES
6.3.4.1 High prevalence of CVD to support demand
TABLE 44 ECG/EKG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.5 TEMPERATURE MONITORING DEVICES
6.3.5.1 Technological innovations and increasing awareness to drive growth
TABLE 45 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.6 HEART RATE MONITORS
6.3.6.1 Continuous cardiac parameter monitoring capabilities to drive demand
TABLE 46 HEART RATE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.7 PULSE OXIMETERS
6.3.7.1 Rising disease incidence and wide usage of pulse oximetry to ensure strong demand
TABLE 47 PULSE OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.8 OVULATION & PREGNANCY TEST KITS
6.3.8.1 Privacy, convenience, accessibility, and quick results to drive market
TABLE 48 OVULATION & PREGNANCY TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.9 BLOOD PRESSURE MONITORS
6.3.9.1 Rising patient population for hypertension and CVD to drive market
TABLE 49 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.10 HIV TEST KITS
6.3.10.1 Rising prevalence of HIV to drive market
TABLE 50 HIV TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.11 FETAL MONITORING DEVICES
6.3.11.1 Remote-based care by portable fetal monitoring systems to drive market growth
TABLE 51 FETAL MONITORING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.12 HOLTER & EVENT MONITORS
6.3.12.1 Rising awareness of preventive care and technological advancements to drive market
TABLE 52 HOLTER & EVENT MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.13 DRUG & ALCOHOL TEST KITS
6.3.13.1 Rising consumption of drugs among teens to support market growth
TABLE 53 DRUG & ALCOHOL TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.14 COAGULATION MONITORING PRODUCTS
6.3.14.1 Rising use of anticoagulant therapy and availability of home-use kits to drive market
TABLE 54 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.15 PEAK FLOW METERS
6.3.15.1 High portability and cost-efficiency to ensure adoption
TABLE 55 PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.16 COLON CANCER TEST KITS
6.3.16.1 High incidence of colorectal cancer to drive market growth
TABLE 56 COLON CANCER TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.17 EEG DEVICES
6.3.17.1 Wide patient population for epilepsy to drive market for EEG devices
TABLE 57 EEG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.18 HOME SLEEP TESTING DEVICES
6.3.18.1 Cost-effectiveness of home-based sleep tests to fuel growth
TABLE 58 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.19 CHOLESTEROL TESTING PRODUCTS
6.3.19.1 Rising obesity levels and CVD incidence to support market
TABLE 59 CHOLESTEROL TESTING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.20 HOME HBA1C TEST KITS
6.3.20.1 High incidence of diabetes to drive market
TABLE 60 HOME HBA1C TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 MOBILITY CARE PRODUCTS
TABLE 61 KEY MOBILITY CARE PRODUCTS AVAILABLE IN THE MARKET
TABLE 62 MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 MOBILITY CARE PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4.1 WHEELCHAIRS
6.4.1.1 Increased preference for wheelchairs to boost demand
TABLE 64 WHEELCHAIRS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4.2 MOBILITY SCOOTERS
6.4.2.1 High cost to affect end-user adoption
TABLE 65 MOBILITY SCOOTERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4.3 WALKERS & ROLLATORS
6.4.3.1 Difficulties in using walkers and availability of alternatives to restrain market
TABLE 66 WALKERS & ROLLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4.4 CRUTCHES
6.4.4.1 High preference for axilla crutches to support demand
TABLE 67 CRUTCHES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4.5 CANES
6.4.5.1 Wide usage of canes to drive market
TABLE 68 CANES MARKET, BY REGION, 2021–2028 (USD MILLION)

7 HOME HEALTHCARE MARKET, BY SERVICE (Page No. – 140)
7.1 INTRODUCTION
TABLE 69 US: AVERAGE SENIOR CARE COST, BY TYPE, 2022
TABLE 70 HOME HEALTHCARE INDUSTRY, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 71 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.2 SKILLED NURSING SERVICES
7.2.1 SKILLED NURSING SERVICES TO DOMINATE MARKET
TABLE 72 SKILLED NURSING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 REHABILITATION THERAPY SERVICES
7.3.1 RISING DEMAND, GROWING GERIATRIC POPULATION, AND INCREASING DISEASE INCIDENCE TO BOOST DEMAND
TABLE 73 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4 HOSPICE & PALLIATIVE CARE SERVICES
7.4.1 RISING GERIATRIC POPULATION TO DRIVE DEMAND
TABLE 74 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.5 UNSKILLED CARE SERVICES
7.5.1 COST-EFFECTIVENESS TO DRIVE GROWTH
TABLE 75 UNSKILLED SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.6 RESPIRATORY THERAPY SERVICES
7.6.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET
TABLE 76 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.7 INFUSION THERAPY SERVICES
7.7.1 SAFETY AND EFFECTIVENESS OF HOME INFUSION TO DRIVE DEMAND
TABLE 77 INFUSION THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.8 PREGNANCY CARE SERVICES
7.8.1 NEED FOR BETTER MANAGEMENT OF HIGH-RISK PREGNANCIES AND COMPLICATIONS TO ENSURE MARKET GROWTH
TABLE 78 PREGNANCY CARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)

8 HOME HEALTHCARE MARKET, BY INDICATION (Page No. – 150)
8.1 INTRODUCTION
TABLE 79 HOME HEALTHCARE INDUSTRY, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 80 HOME HEALTHCARE INDICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2 CANCER
8.2.1 CANCER TO DOMINATE INDICATIONS MARKET
TABLE 81 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
TABLE 82 MARKET FOR CANCER, BY REGION, 2021–2028 (USD MILLION)
8.3 RESPIRATORY DISEASES
8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET
TABLE 83 MARKET FOR RESPIRATORY DISEASES, BY REGION, 2021–2028 (USD MILLION)
8.4 MOVEMENT DISORDERS
8.4.1 GROWING GERIATRIC POPULATION TO DRIVE DEMAND FOR THERAPY EQUIPMENT
TABLE 84 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2021–2028 (USD MILLION)
8.5 PREGNANCY
8.5.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH
TABLE 85 MARKET FOR PREGNANCY, BY REGION, 2021–2028 (USD MILLION)
8.6 CVD & HYPERTENSION
8.6.1 RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE GROWTH
TABLE 86 MARKET FOR CVD & HYPERTENSION, BY REGION, 2021–2028 (USD MILLION)
8.7 WOUND CARE
8.7.1 GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET
TABLE 87 MARKET FOR WOUND CARE, BY REGION, 2021–2028 (USD MILLION)
8.8 DIABETES
8.8.1 INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH
TABLE 88 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2021–2028 (USD MILLION)
8.9 HEARING DISORDERS
8.9.1 WORLDWIDE INCREASE IN HEARING DISABILITIES TO ENSURE SUSTAINED GROWTH
TABLE 89 MARKET FOR HEARING DISORDERS, BY REGION, 2021–2028 (USD MILLION)
8.10 OTHER INDICATIONS
TABLE 90 HOME HEALTHCARE INDUSTRY FOR OTHER INDICATIONS, BY REGION, 2021–2028 (USD MILLION)

9 HOME HEALTHCARE MARKET, BY REGION (Page No. – 161)
9.1 INTRODUCTION
TABLE 91 HOME HEALTHCARE INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 28 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT
TABLE 92 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 94 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 95 NORTH AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 96 NORTH AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 98 NORTH AMERICA: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.2.2 US
9.2.2.1 US to dominate North American home healthcare market
TABLE 100 US: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 101 US: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 102 US: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 103 US: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 US: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 US: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 106 US: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Rising geriatric population to drive market
TABLE 107 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 108 CANADA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 109 CANADA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 CANADA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 111 CANADA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 112 CANADA: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 113 CANADA: MARKET, BY INDICATION, 2021–2028 (USD MILLION)

9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
TABLE 114 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 115 EUROPE: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 116 EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 117 EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 118 EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 119 EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 EUROPE: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 121 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Germany to retain market leadership in Europe
TABLE 122 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 123 GERMANY: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 124 GERMANY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 125 GERMANY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 GERMANY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 GERMANY: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 128 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.3.3 UK
9.3.3.1 Rising burden of chronic diseases to boost market growth
TABLE 129 UK: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 130 UK: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 131 UK: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 UK: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 133 UK: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 134 UK: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 135 UK: MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 Government support and initiatives taken by market players to boost market
TABLE 136 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 137 FRANCE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 138 FRANCE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 139 FRANCE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 FRANCE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 FRANCE: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 142 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Rising geriatric population and favorable government policy to drive market
TABLE 143 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 144 ITALY: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 145 ITALY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 ITALY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 147 ITALY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 148 ITALY: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 149 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Rising geriatric population and incidence of chronic conditions to drive market growth
TABLE 150 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 151 SPAIN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 152 SPAIN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 153 SPAIN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 154 SPAIN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 155 SPAIN: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 156 SPAIN: MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 157 REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 158 REST OF EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 159 REST OF EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 160 REST OF EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 REST OF EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 REST OF EUROPE: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 163 REST OF EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 29 APAC: HOME HEALTHCARE MARKET SNAPSHOT
TABLE 164 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 165 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 166 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 167 ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 ASIA PACIFIC: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 171 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Japan to command largest share of APAC market
TABLE 172 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 173 JAPAN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 174 JAPAN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 175 JAPAN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 176 JAPAN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 JAPAN: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 178 JAPAN: MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Healthcare development and reforms to drive market growth
TABLE 179 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 180 CHINA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 181 CHINA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 CHINA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 183 CHINA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 184 CHINA: HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 185 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Increasing target patient population to drive market
TABLE 186 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 187 INDIA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 188 INDIA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 INDIA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 INDIA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 INDIA: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 192 INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 193 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 194 REST OF ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 195 REST OF ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 196 REST OF ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 REST OF ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 REST OF ASIA PACIFIC: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 199 REST OF ASIA PACIFIC: MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.5 REST OF THE WORLD
9.5.1 REST OF THE WORLD: RECESSION IMPACT
TABLE 200 ROW: HOME HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 201 ROW: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 202 ROW: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 203 ROW: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 ROW: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 ROW: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 206 ROW: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 207 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.5.2 LATIN AMERICA
9.5.2.1 Aging population to favor market growth
TABLE 208 LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 209 LATIN AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 210 LATIN AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 211 LATIN AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 212 LATIN AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 LATIN AMERICA: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 214 LATIN AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.5.3 MIDDLE EAST & AFRICA
TABLE 215 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA: MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.5.3.1 GCC Countries
9.5.3.1.1 Rising focus on expanding and improving health infrastructure to drive market
TABLE 223 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 224 GCC COUNTRIES: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 225 GCC COUNTRIES: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 226 GCC COUNTRIES: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 227 GCC COUNTRIES: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 228 GCC COUNTRIES: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 229 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
9.5.3.2 Rest of the Middle East & Africa
TABLE 230 ROMEA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 231 ROMEA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 232 ROMEA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 233 ROMEA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 234 ROMEA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 ROMEA: MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 236 ROMEA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 266)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS
TABLE 237 OVERVIEW OF STRATEGIES DEPLOYED BY KEY HOME HEALTHCARE PRODUCT MANUFACTURERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS
10.4 MARKET SHARE ANALYSIS
FIGURE 31 HOME HEALTHCARE MARKET SHARE ANALYSIS (2022)
TABLE 238 HOME HEALTHCARE INDUSTRY: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 32 HOME HEALTHCARE INDUSTRY: COMPANY EVALUATION MATRIX, 2022
10.5.5 COMPANY FOOTPRINT
TABLE 239 PRODUCT FOOTPRINT (FIVE PLAYERS)
TABLE 240 REGIONAL FOOTPRINT (FIVE PLAYERS)
TABLE 241 COMPETITIVE BENCHMARKING OF KEY PLAYERS
FIGURE 33 COMPANY FOOTPRINT (FIVE COMPANIES)
10.6 START-UP/SME EVALUATION MATRIX
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
FIGURE 34 HOME HEALTHCARE INDUSTRY: START-UP/SME EVALUATION MATRIX, 2022
10.6.5 COMPETITIVE BENCHMARKING
TABLE 242 HOME HEALTHCARE INDUSTRY: DETAILED LIST OF KEY START-UPS/SMES
TABLE 243 COMPETITIVE BENCHMARKING OF START-UPS/SMES
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 244 HOME HEALTHCARE INDUSTRY: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
10.7.2 DEALS
TABLE 245 HOME HEALTHCARE INDUSTRY: DEALS (JANUARY 2020–DECEMBER 2023)
10.7.3 OTHER DEVELOPMENTS
TABLE 246 HOME HEALTHCARE INDUSTRY: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
11 COMPANY PROFILES (Page No. - 279)
(Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS
11.1.1 FRESENIUS SE & CO. KGAA
TABLE 247 FRESENIUS SE & CO. KGAA: COMPANY OVERVIEW
FIGURE 35 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT (2022)
TABLE 248 FRESENIUS SE & CO. KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 249 FRESENIUS SE & CO. KGAA: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 250 FRESENIUS SE & CO. KGAA: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 251 FRESENIUS SE & CO. KGAA: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
11.1.2 ABBOTT
TABLE 252 ABBOTT: COMPANY OVERVIEW
FIGURE 36 ABBOTT: COMPANY SNAPSHOT (2022)
TABLE 253 ABBOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 254 ABBOTT: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 255 ABBOTT: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.3 LINDE PLC
TABLE 256 LINDE: COMPANY OVERVIEW
FIGURE 37 LINDE: COMPANY SNAPSHOT (2022)
TABLE 257 LINDE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
11.1.4 F. HOFFMANN-LA ROCHE
TABLE 258 F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW
FIGURE 38 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022)
TABLE 259 F. HOFFMAN-LA ROCHE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 260 F. HOFFMAN-LA ROCHE: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 261 F. HOFFMANN-LA ROCHE: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.5 RESMED
TABLE 262 RESMED: COMPANY OVERVIEW
FIGURE 39 RESMED: COMPANY SNAPSHOT (2022)
TABLE 263 RESMED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 264 RESMED: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 265 RESMED: DEALS
11.1.6 KONINKLIJKE PHILIPS
TABLE 266 KONINKLIJKE PHILIPS: COMPANY OVERVIEW
FIGURE 40 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2022)
TABLE 267 KONINKLIJKE PHILIPS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 268 KONINKLIJKE PHILIPS: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 269 KONINKLIJKE PHILIPS: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.7 GE HEALTHCARE
TABLE 270 GE HEALTHCARE: COMPANY OVERVIEW
FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
TABLE 271 GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 272 GE HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.8 A&D COMPANY
TABLE 273 A&D COMPANY: COMPANY OVERVIEW
FIGURE 42 A&D COMPANY: COMPANY SNAPSHOT (2022)
TABLE 274 A&D COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 275 A&D COMPANY: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
11.1.9 INVACARE CORPORATION
TABLE 276 INVACARE CORPORATION: COMPANY OVERVIEW
FIGURE 43 INVACARE CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 277 INVACARE CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 278 INVACARE CORPORATION: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
11.1.10 AMEDISYS
TABLE 279 AMEDISYS: COMPANY OVERVIEW
FIGURE 44 AMEDISYS: COMPANY SNAPSHOT (2022)
TABLE 280 AMEDISYS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 281 AMEDISYS: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.11 LHC GROUP
TABLE 282 LHC GROUP: COMPANY OVERVIEW
FIGURE 45 LHC GROUP: COMPANY SNAPSHOT (2022)
TABLE 283 LHC GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 284 LHC GROUP: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.12 OMRON CORPORATION
TABLE 285 OMRON CORPORATION: COMPANY OVERVIEW
FIGURE 46 OMRON CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 286 OMRON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 287 OMRON CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 288 OMRON CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
11.2 OTHER PLAYERS
11.2.1 BAYADA HOME HEALTH CARE
11.2.2 DRIVE DEVILBISS HEALTHCARE LIMITED
11.2.3 SUNRISE MEDICAL
11.2.4 ROMA MEDICAL
11.2.5 CAREMAX REHABILITATION EQUIPMENT
11.2.6 VITALOGRAPH
11.2.7 ADVITA PFLEGEDIENST
11.2.8 RENAFAN GMBH
11.2.9 CONTEC MEDICAL SYSTEMS
11.2.10 B. BRAUN MELSUNGEN AG
11.2.11 BAXTER INTERNATIONAL
11.2.12 MEDLINE INDUSTRIES
11.2.13 ADVIN HEALTH CARE

*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 344)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

※関連データはありません。

※注目の調査資料
 ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MD1160-24 )"在宅医療のグローバル市場予測（～2028）：透析装置、人工呼吸器、HIV検査キット、補聴器、活動モニタ" (英文：Home Healthcare Market by Product (Dialysis Equipment, Ventilators, HIV Test Kits, Hearing Aids, Activity Monitors), Service (Skilled Nursing, Infusion Therapy, Palliative Care), Indication (Cancer, Wound Care, Diabetes), & Region- Global Forecast to 2028)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

◆H&Iグローバルリサーチのお客様（例）◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。